The DOI matches its Crossref record; 287 of the 287 references it cites were found in a registry or an index.
Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management
Open accessAbstract
SUMMARY: The only natural reservoir of Neisseria meningitidis is the human nasopharyngeal mucosa. Depending on age, climate, country, socioeconomic status, and other factors, approximately 10% of the human population harbors meningococci in the nose. However, invasive disease is relatively rare, as it occurs only when the following conditions are fulfilled: (i) contact with a virulent strain, (ii) colonization by that strain, (iii) penetration of the bacterium through the mucosa, and (iv) survival and eventually outgrowth of the meningococcus in the bloodstream. When the meningococcus has reached the bloodstream and specific antibodies are absent, as is the case for young children or after introduction of a new strain in a population, the ultimate outgrowth depends on the efficacy of the innate immune response. Massive outgrowth leads within 12 h to fulminant meningococcal sepsis (FMS), characterized by high intravascular concentrations of endotoxin that set free high concentrations of proinflammatory mediators. These mediators belonging to the complement system, the contact system, the fibrinolytic system, and the cytokine system induce shock and diffuse intravascular coagulation. FMS can be fatal within 24 h, often before signs of meningitis have developed. In spite of the increasing possibilities for treatment in intensive care units, the mortality rate of FMS is still 30%. When the outgrowth of meningococci in the bloodstream is impeded, seeding of bacteria in the subarachnoidal compartment may lead to overt meningitis within 24 to 36 h. With appropriate antibiotics and good clinical surveillance, the mortality rate of this form of invasive disease is 1 to 2%. The overall mortality rate of meningococcal disease can only be reduced when patients without meningitis, i.e., those who may develop FMS, are recognized early. This means that the fundamental nature of the disease as a meningococcus septicemia deserves more attention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics
Selander, R. K., Caugant, D. A., Ochman, H., Musser, J. M., Gilmour, M. N., & Whittam, T. S. (1986) · Applied and Environmental Microbiology · doi:10.1128/aem.51.5.873-884.1986 · Cited by 1,385
Acute Bacterial Meningitis in Adults -- A Review of 493 Episodes
Durand, M. L., Calderwood, S. B., Weber, D. J., Miller, S. I., Southwick, F. S., Caviness, V. S., & Swartz, M. N. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301073280104 · Cited by 1,344
HUMAN IMMUNITY TO THE MENINGOCOCCUS
Goldschneider, I., Gotschlich, E. C., & Artenstein, M. S. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.129.6.1307 · Cited by 1,294
Bacterial Meningitis in the United States in 1995
Schuchat, A., Robinson, K., Wenger, J. D., Harrison, L. H., Farley, M., Reingold, A. L., Lefkowitz, L., & Perkins, B. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371404 · Cited by 1,251
Waage, A., Brandtzaeg, P., Halstensen, A., Kierulf, P., & Espevik, T. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.1.333 · Cited by 1,173
Self-citationWaage, A., Halstensen, A., & Espevik, T. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91728-4 · Cited by 1,096
HUMAN IMMUNITY TO THE MENINGOCOCCUS
Goldschneider, I., Gotschlich, E. C., & Artenstein, M. S. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.129.6.1327 · Cited by 995
Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.
Taylor, F. B., Chang, A., Esmon, C. T., D'Angelo, A., Vigano-D'Angelo, S., & Blick, K. E. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112902 · Cited by 821
Genetic influence on cytokine production and fatal meningococcal disease
Westendorp, R. G., Langermans, J. A., Huizinga, T. W., Elouali, A. H., Verweij, C. L., Boomsma, D. I., & Vandenbrouke, J. P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)06413-6 · Cited by 800
ANTIGENIC SIMILARITIES BETWEEN BRAIN COMPONENTS AND BACTERIA CAUSING MENINGITIS
Finne, J., Leinonen, M., & Mäkelä, P. H. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90340-9 · Cited by 796
Kumar, A., Thota, V, Dee, L., Olson, J., Uretz, E., & Parrillo, J. E. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.949 · Cited by 791
Sprung, C. L., Caralis, P. V., Marcial, E. H., Pierce, M., Gelbard, M. A., Long, W. M., Duncan, R. C., Tendler, M. D., & Karpf, M. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411013111801 · Cited by 765
Tumor Necrosis Factor and Interleuktn-1 in the Serum of Children with Severe Infectious Purpura
Girardin, E., Grau, G. E., Dayer, J.-M., Roux-Lombard, P., the J5 Study Group*, & Lambert, P.-H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198808183190703 · Cited by 737
Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway
Bjune, G., Høiby, E. A., Grønnesby, J. K., Arnesen, Ø., Fredriksen, J. H., Lindbak, A.-K., Nøkleby, H., Rosenqvist, E., Solberg, L. K., Closs, O., et al. (1991) · The Lancet · doi:10.1016/0140-6736(91)91961-s · Cited by 694
Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment
Zeni, F., Freeman, B., & Natanson, C. (1997) · Critical Care Medicine · doi:10.1097/00003246-199707000-00001 · Cited by 648
Ross, S. C., & Densen, P. (1984) · PubMed · Cited by 630
Corticosteroid treatment for sepsis: A critical appraisal and meta-analysis of the literature
Cronin, L., Cook, D. J., Carlet, J., Heyland, D. K., King, D. B. M., Lansang, M. A. D., & Fisher, Jr. (1995) · Critical Care Medicine · doi:10.1097/00003246-199508000-00019 · Cited by 622
Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications
Hermaszewski, R. A., & WEBSTER, A. D. B. (1993) · QJM · doi:10.1093/oxfordjournals.qjmed.a068735 · Cited by 567
Brandtzaeg, P., Kierulf, P., Gaustad, P., Skulberg, A., Bruun, J. N., Halvorsen, S., & Sorensen, E. (1989) · Journal of Infectious Diseases · doi:10.1093/infdis/159.2.195 · Cited by 553
Self-citationROSS, S. C., & DENSEN, P. (1984) · Medicine · doi:10.1097/00005792-198409000-00001 · Cited by 550
Sierra, G. V. G., Campa, H. C., Varcacel, N. M., Garcia, I. L., Izquierdo, P., Sotolongo, P. F., Casanueva, G. V., Rico, C. O., Rodriguez, C. R., & Terry, M. H. (1991) · PubMed · Cited by 512
Outcomes of bacterial meningitis in children: a meta-analysis
BARAFF, L. J., LEE, S. I., & SCHRIGER, D. L. (1993) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199305000-00008 · Cited by 495
Treatment of Bacterial Meningitis
Quagliarello, V. J., & Scheld, W. M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703063361007 · Cited by 491
Bacterial Meningitis: Pathogenesis, Pathophysiology, and Progress
Epstein, F. H., Quagliarello, V., & Scheld, W. M. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209173271208 · Cited by 488
Steroid controversy in sepsis and septic shock: A meta-analysis
Lefering, R., & Neugebauer, E. A. M. (1995) · Critical Care Medicine · doi:10.1097/00003246-199507000-00021 · Cited by 485
Anti-inflammatory cytokine profile and mortality in febrile patients
VANDISSEL, J., VANLANGEVELDE, P., WESTENDORP, R., KWAPPENBERG, K., & FROLICH, M. (1998) · The Lancet · doi:10.1016/s0140-6736(00)80013-6 · Cited by 482
Serotype Antigens of Neisseria meningitidis and a Proposed Scbemefor Designation of Serotypes
Frasch, C. E., Zollinger, W. D., & Poolman, J. T. (1985) · Clinical Infectious Diseases · doi:10.1093/clinids/7.4.504 · Cited by 460
Waage, A., Halstensen, A., Shalaby, R., Brandtzaeg, P., Kierulf, P., & Espevik, T. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.6.1859 · Cited by 454
Self-citationLethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody.
Taylor, F. B., Chang, A. C. K., Ruf, W., Morrissey, J. H., Hinshaw, L. B., Catlett, R., Blick, K. E., & Edgington, T. S. (1991) · PubMed · Cited by 434
The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica
Cartwright, K. A. V., Stuart, J. M., Jones, D. M., & Noah, N. D. (1987) · Epidemiology and Infection · doi:10.1017/s0950268800066449 · Cited by 421
X-Linked Agammaglobulinemia: An Analysis of 96 Patients
LEDERMAN, H. M., & WINKELSTEIN, J. A. (1985) · Medicine · doi:10.1097/00005792-198505000-00001 · Cited by 411
Role of tumor necrosis factor-α in disease states and inflammation
STRIETER, R. M., KUNKEL, S. L., & BONE, R. C. (1993) · Critical Care Medicine · doi:10.1097/00003246-199310001-00006 · Cited by 411
HUMAN IMMUNITY TO THE MENINGOCOCCUS
Gotschlich, E. C., Goldschneider, I., & Artenstein, M. S. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.129.6.1367 · Cited by 402
Meningococcal Disease: Still with Us
Peltola, H. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.1.71 · Cited by 394
Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia.
Pajkrt, D., Doran, J. E., Koster, F., Lerch, P. G., Arnet, B., van der Poll, T., ten Cate, J. W., & van Deventer, S. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.5.1601 · Cited by 390
Capsule switching of Neisseria meningitidis
Swartley, J. S., Marfin, A. A., Edupuganti, S., Liu, L.-J., Cieslak, P., Perkins, B., Wenger, J. D., & Stephens, D. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.271 · Cited by 383
Quagliarello, V. J., Wispelwey, B., Long, W. J., & Scheld, W. M. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115140 · Cited by 372
Hibberd, M. L., Sumiya, M., Summerfield, J. A., Booy, R., & Levin, M. (1999) · The Lancet · doi:10.1016/s0140-6736(98)08350-0 · Cited by 372
Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil
Cassio de Moraes, J., Camargo, M. C. C., Rossetto Hidalgo, N. T., Aparecida Barbosa, H., Gattas, V. L., Vasconcelos, H. D. G., Tavares Sacchi, C., Land Gral, I. M., Perkins, B. A., Wenger, J. D., et al. (1992) · The Lancet · doi:10.1016/0140-6736(92)93086-3 · Cited by 366
Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria
Källström, H., Liszewski, M. K., Atkinson, J. P., & Jonsson, A. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.4841857.x · Cited by 358
Pathogenesis of Disseminated Intravascular Coagulation in Sepsis
Levi, M. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510080079035 · Cited by 349
Role of Early Fluid Resuscitation in Pediatric Septic Shock
Carcillo, J. A. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470090076035 · Cited by 345
Peltola, H., Mäkelä, P. H., Käyhty, H., Jousimies, H., Herva, E., Hällström, K., Sivonen, A., Renkonen, O.-V., Pettay, O., Karanko, V., et al. (1977) · New England Journal of Medicine · doi:10.1056/nejm197709292971302 · Cited by 344
Bender, A. E. (1974) · PubMed · Cited by 337
Eisele, B., Heinrichs, H., Delvos, U., Lamy, M., Thijs, L. G., Keinecke, H. O., Schuster, H. P., Matthias, F. R., & Fourrier, F. (1998) · Intensive Care Medicine · doi:10.1007/s001340050642 · Cited by 336
Hermans, P. W., Hibberd, M. L., Booy, R., Daramola, O., Hazelzet, J. A., de Groot, R., & Levin, M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02220-5 · Cited by 323
Carriage of Neisseria meningitidis and Neisseria lactamica in Infants and Children
Gold, R., Goldschneider, I., Lepow, M. L., Draper, T. F., & Randolph, M. (1978) · Journal of Infectious Diseases · doi:10.1093/infdis/137.2.112 · Cited by 322
Cerebrospinal meningitis in Africa.
Lapeyssonnie, L. (1963) · Europe PMC (PubMed Central) · Cited by 321
Østerud, B., & Flægstad, T. (1983) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657303 · Cited by 319
Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population
Caugant, D. A., Høiby, E. A., Magnus, P., Scheel, O., Hoel, T., Bjune, G., Wedege, E., Eng, J., & Frøholm, L. O. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.2.323-330.1994 · Cited by 312
Tunkel, A. R. (2001) · Cited by 308
Nadel, S., Newport, M. J., Booy, R., & Levin, M. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.4.878 · Cited by 305
LEVI, M., VAN DER POLL, T., TEN CATE, H., & VAN DEVENTER, S. J. H. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.570614.x · Cited by 305
RELEASE OF ENDOTOXIN IN THE FORM OF CELL WALL BLEBS DURING IN VITRO GROWTH OF NEISSERIA MENINGITIDIS
Devoe, I. W., & Gilchrist, J. E. (1973) · The Journal of Experimental Medicine · doi:10.1084/jem.138.5.1156 · Cited by 298
Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation.
Ramilo, O., Sáez-Llorens, X., Mertsola, J., Jafari, H., Olsen, K. D., Hansen, E. J., Yoshinaga, M., Ohkawara, S., Nariuchi, H., & McCracken, G. H. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.2.497 · Cited by 294
Role of early fluid resuscitation in pediatric septic shock
Magid, D. (1992) · The Journal of Emergency Medicine · doi:10.1016/0736-4679(92)90361-v · Cited by 294
Seizures and Other Neurologic Sequelae of Bacterial Meningitis in Children
Pomeroy, S. L., Holmes, S. J., Dodge, P. R., & Feigin, R. D. (1990) · New England Journal of Medicine · doi:10.1056/nejm199012133232402 · Cited by 280
Pathogenesis and pathophysiology of bacterial meningitis
Tunkel, A. R., & Scheld, W. M. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.2.118 · Cited by 279
Pixley, R. A., De La Cadena, R., Page, J. D., Kaufman, N., Wyshock, E. G., Chang, A., Taylor, F. B., & Colman, R. W. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116201 · Cited by 278
Early treatment with parenteral penicillin in meningococcal disease.
Cartwright, K., Reilly, S., White, D., & Stuart, J. (1992) · BMJ · doi:10.1136/bmj.305.6846.143 · Cited by 265
Morrison, D. C., & Cochrane, C. G. (1974) · The Journal of Experimental Medicine · doi:10.1084/jem.140.3.797 · Cited by 264
Serogroup C meningococcal outbreaks in the United States. An emerging threat
Jackson, L. A. (1995) · JAMA · doi:10.1001/jama.273.5.383 · Cited by 256
Population genetics and molecular epidemiology of Neisseria meningitidis
CAUGANT, D. A. (1998) · APMIS · doi:10.1111/j.1699-0463.1998.tb01379.x · Cited by 255
Tauber, M. G., Khayam-Bashi, H., & Sande, M. A. (1985) · Journal of Infectious Diseases · doi:10.1093/infdis/151.3.528 · Cited by 254
Virji, M., Watt, S. M., Barker, S., Makepeace, K., & Doyonnas, R. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.01548.x · Cited by 243
Smith, O., White, B., Vaughan, D., Rafferty, M., Claffey, L., Lyons, B., & Casey, W. (1997) · The Lancet · doi:10.1016/s0140-6736(97)06356-3 · Cited by 233
van der Poll, T., & Lowry, S. F. (1995) · Shock · doi:10.1097/00024382-199501000-00001 · Cited by 230
Brandtzaeg, P., Osnes, L., Ovstebø, R., Joø, G. B., Westvik, A. B., & Kierulf, P. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.1.51 · Cited by 229
Self-citationGlobal epidemiology of meningococcal disease
Schwartz, B., Moore, P. S., & Broome, C. V. (1989) · Clinical Microbiology Reviews · doi:10.1128/cmr.2.suppl.s118 · Cited by 227
INTERCONTINENTAL SPREAD OF AN EPIDEMIC GROUP A NEISSERIA MENINGITIDIS STRAIN
MOORE, P. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90439-x · Cited by 227
van Deuren, M., van der Ven-Jongekrijg, J., Bartelink, A. K. M., van Dalen, R., Sauerwein, R. W., & van der Meer, J. W. M. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/172.2.433 · Cited by 225
Self-citationPathophysiology, Treatment and Outcome of Meningococcemia: A Review and Recent Experience
KIRSCH, E. A., BARTON, R. P., KITCHEN, L., & GIROIR, B. P. (1996) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199611000-00009 · Cited by 221
Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock
Westendorp, R. G., Hottenga, J.-J., & Slagboom, P. E. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09376-3 · Cited by 213
Tobacco smoke as a risk factor for meningococcal disease
FISCHER, M., HEDBERG, K., CARDOSI, P., PLIKAYTIS, B. D., HOESLY, F. C., STEINGART, K. R., BELL, T. A., FLEMING, D. W., WENGER, J. D., & PERKINS, B. A. (1997) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199710000-00015 · Cited by 210
Influenza A and meningococcal disease
Cartwright, K. A. V., Jones, D. M., Kaczmarski, E., Smith, A. J., Stuart, J. M., & Palmer, S. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)91112-8 · Cited by 205
Girardin, E. P., Roux-Lombard, P., Grau, G. E., Suter, P. M., Gallati, H., & Dayer, J. (1992) · PubMed Central · Cited by 203
Meningococcal Meningitis in Sub-Saharan Africa: A Model for the Epidemic Process
Moore, P. S. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.2.515 · Cited by 199
Complement Activation and Endotoxin Levels in Systemic Meningococcal Disease
Brandtzaeg, P., Mollnes, T. E., & Kierulf, P. (1989) · Journal of Infectious Diseases · doi:10.1093/infdis/160.1.58 · Cited by 197
Self-citationFca Receptor Iia (Cd32) Polymorphism In Fulminant Meningococcal Septic
Bredius, R. G. M., Derkx, B. H. F., Fijen, C. A. P., de Wit, T. P. M., Haas, M. D., Weening, R. S., van de Winkel, J. G. J., & Out, T. A. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/170.4.848 · Cited by 192
Uncloaking the meningococcus: dynamics of carriage and disease
Stephens, D. S. (1999) · The Lancet · doi:10.1016/s0140-6736(98)00279-7 · Cited by 192
A Simultaneous Outbreak of Meningococcal and Influenza Infections
Young, L. S., LaForce, F. M., Head, J. J., Feeley, J. C., & Bennett, J. V. (1972) · New England Journal of Medicine · doi:10.1056/nejm197207062870102 · Cited by 192
Cerebral herniation during bacterial meningitis in children.
Rennick, G., Shann, F., & de Campo, J. (1993) · BMJ · doi:10.1136/bmj.306.6883.953 · Cited by 191
Nuijens, J., Huijbregts, C., Eerenberg-Belmer, A., Abbink, J., Strack van Schijndel, R., Felt-Bersma, R., Thijs, L., & Hack, C. (1988) · Blood · doi:10.1182/blood.v72.6.1841.1841 · Cited by 188
Respiratory Viruses and Mycoplasma as Cofactors for Epidemic Group A Meningococcal Meningitis
Moore, P. S. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450100061026 · Cited by 186
Treatment of purpura fulminans in meningococcemia with protein C concentrate
Rivard, G. E., David, M., Farrell, C., & Schwarz, H. P. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70369-1 · Cited by 185
Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation
Jarvis, G. A., & Vedros, N. A. (1987) · Infection and Immunity · doi:10.1128/iai.55.1.174-180.1987 · Cited by 182
Fijnvandraat, K., Derkx, B., Peters, M., Bijlmer, R., Sturk, A., Prins, M. H., Deventer, S. J. H. V., & ten Cate, J. W. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1651669 · Cited by 182
Virji, M., Makepeace, K., Peak, I. R. A., Ferguson, D. J. P., Jennings, M. P., & Moxon, E. R. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.mmi_18040741.x · Cited by 181
Dexamethasone Therapy for Children With Bacterial Meningitis
Wald, E. R., Kaplan, S. L., Mason, E. O., Sabo, D., Md, L. R., Arditi, M., Wiedermann, B. L., Barson, W., Kim, K. S., Yogev, R., et al. (1995) · Pediatrics · doi:10.1542/peds.95.1.21 · Cited by 180
Cartwright, K., Morris, R., Rümke, H., Fox, A., Borrow, R., Begg, N., Richmond, P., & Poolman, J. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00044-4 · Cited by 176
THE RESULTS OF THE SERUM TREATMENT IN THIRTEEN HUNDRED CASES OF EPIDEMIC MENINGITIS
Flexner, S. (1913) · Journal of Experimental Medicine · doi:10.1084/jem.17.5.553 · Cited by 176
Giroir, B. P., Quint, P. A., Barton, P., Kirsch, E. A., Kitchen, L., Goldstein, B., Nelson, B. J., Wedel, N. I., Carroll, S. F., & Scannon, P. J. (1997) · The Lancet · doi:10.1016/s0140-6736(97)06468-4 · Cited by 176
Factors in the prognosis ofmeningococcal infection
Stiehm, E. R., & Damrosch, D. S. (1966) · The Journal of Pediatrics · doi:10.1016/s0022-3476(66)80250-0 · Cited by 173
Plasma elastase levels and the development of the adult respiratory distress syndrome.
Donnelly, S. C., MacGregor, I., Zamani, A., Gordon, M. W., Robertson, C. E., Steedman, D. J., Little, K., & Haslett, C. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.5.7735596 · Cited by 173
Complications and Sequelae of Meningococcal Disease in Quebec, Canada, 1990–1994
Erickson, L., & De Wals, P. (1998) · Clinical Infectious Diseases · doi:10.1086/520303 · Cited by 172
van Deuren, M., van der Ven Jongekrijg, J., Demacker, P. N. M., Bartelink, A. K. M., van Dalen, R., Sauerwein, R. W., Gallati, H., Vannice, J. L., & van der Meer, J. W. M. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/169.1.157 · Cited by 170
Self-citationBrandtzaeg, P., Sandset, P. M., Joø, G. B., Øvstebø, R., Abildgaard, U., & Kierulf, P. (1989) · Thrombosis Research · doi:10.1016/0049-3848(89)90054-6 · Cited by 169
Self-citationStephens, D. S., Hoffman, L. H., & McGee, Z. A. (1983) · Journal of Infectious Diseases · doi:10.1093/infdis/148.3.369 · Cited by 168
Meningococcal Carriage in a Population of "Normal" Families
Greenfield, S., Sheehe, P. R., & Feldman, H. A. (1971) · Journal of Infectious Diseases · doi:10.1093/infdis/123.1.67 · Cited by 168
Adrenal insufficiency in septic shock
Hatherill, M., Tibby, S. M., Hilliard, T. N., Turner, C., & Murdoch, I. (1999) · Archives of Disease in Childhood · doi:10.1136/adc.80.1.51 · Cited by 167
Lebel, M. H., & McCracken, G. H. (1989) · Pediatrics · doi:10.1542/peds.83.2.161 · Cited by 165
Tauber, M. G., Shibl, A. M., Hackbarth, C. J., Larrick, J. W., & Sande, M. A. (1987) · Journal of Infectious Diseases · doi:10.1093/infdis/156.3.456 · Cited by 165
Antibiotic-Induced Release of Endotoxin: A Reappraisal
Hurley, J. C. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.5.840 · Cited by 164
Corrigan, J. J., & Jordan, C. M. (1970) · New England Journal of Medicine · doi:10.1056/nejm197010082831502 · Cited by 163
Kahler, C. M., Martin, L. E., Shih, G. C., Rahman, M. M., Carlson, R. W., & Stephens, D. S. (1998) · Infection and Immunity · doi:10.1128/iai.66.12.5939-5947.1998 · Cited by 162
Cell Signaling by the Type IV Pili of Pathogenic Neisseria
Källström, H., Islam, M. S., Berggren, P.-O., & Jonsson, A.-B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.34.21777 · Cited by 161
The role of neisserial Opa proteins in interactions with host cells
Dehio, C. (1998) · Trends in Microbiology · doi:10.1016/s0966-842x(98)01365-1 · Cited by 161
Group A Meningococcal Carriage in Travelers Returning From Saudi Arabia
Moore, P. S., Harrison, L. H., Telzak, E. E., Ajello, G. W., & Broome, C. V. (1988) · JAMA · doi:10.1001/jama.1988.03410180094036 · Cited by 160
Derkx, B., Wittes, J. T., McCloskey, R. V., & the European Pediatric Meningococcal Septic Shock Trial Study Group (1999) · Clinical Infectious Diseases · doi:10.1086/515184 · Cited by 156
Smoking, the environment and meningococcal disease: a case control study
Stanwell, R. E., Stuart, J. M., Hughes, A., Robinson, P. M., Griffin, M., & Cartwright, K. A. V. (1994) · Epidemiology and Infection · doi:10.1017/s0950268800057733 · Cited by 156
Stephens, D. S., & McGee, Z. A. (1981) · The Journal of Infectious Diseases · doi:10.1093/infdis/143.4.525 · Cited by 156
High-Level Chloramphenicol Resistance inNeisseria meningitidis
Galimand, M., Gerbaud, G., Guibourdenche, M., Riou, J., & Courvalin, P. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809243391302 · Cited by 156
Argenbright, L. W., & Barton, R. W. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115570 · Cited by 155
Brandtzaeg, P., Joø, G. B., Brusletto, B. S., & Kierulf, P. (1990) · Thrombosis Research · doi:10.1016/0049-3848(90)90326-8 · Cited by 154
Self-citationEpidemic Meningococcemia and Purpura Fulminans with Induced Protein C Deficiency
Powars, D., Larsen, R. A., Johnson, J. V., Hulbert, T. V., Sun, T., Patch, M. J., Francis, R. B., & Chan, L. S. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.2.254 · Cited by 154
Complications and sequelae of meningococcalinfections in children
Edwards, M. S., & Baker, C. J. (1981) · The Journal of Pediatrics · doi:10.1016/s0022-3476(81)80250-8 · Cited by 154
Kim, K. S., Wass, C. A., Cross, A. S., & Opal, S. M. (1992) · PubMed · Cited by 151
Clinical relevance of antibiotic-induced endotoxin release
Prins, J. M., van Deventer, S. J., Kuijper, E. J., et al. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1211 · Cited by 151
Mechanisms of Mucosal Invasion by Pathogenic Neisseria
McGee, Z. A., Stephens, D. S., Hoffman, L. H., Schlech, W. F., & Horn, R. G. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.supplement_4.s708 · Cited by 151
IgA Protease Production as a Characteristic Distinguishing Pathogenic from Harmless Neisseriaceae
Mulks, M. H., & Plaut, A. G. (1978) · New England Journal of Medicine · doi:10.1056/nejm197811022991802 · Cited by 151
Sharief, M., Ciardi, M., & Thompson, E. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/166.2.350 · Cited by 146
Scholten, R. J. P. M., Kuipers, B., Valkenburg, H. A., Dankert, J., Zollinger, W. D., & POOLMAN, J. T. (1994) · Journal of Medical Microbiology · doi:10.1099/00222615-41-4-236 · Cited by 146
Strang, J., & Pugh, E. J. (1992) · BMJ · doi:10.1136/bmj.305.6846.141 · Cited by 144
Bjorvatn, B., Bjertnæs, L. J., FADNES, H. O., Flægstad, T., Gutteberg, T. J., Kristiansen, B., Pape, J., Rekvig, O. P., Østerud, B., & Aanderud, L. (1984) · BMJ · doi:10.1136/bmj.288.6415.439 · Cited by 144
Fourrier, F., Lestavel, P., Chopin, C., Marey, A., Goudemand, J., Rime, A., & Mangalaboyi, J. (1990) · Intensive Care Medicine · doi:10.1007/bf02575306 · Cited by 143
Powell, K. R., Sugarman, L. I., Eskenazi, A. E., Woodin, K. A., Kays, M. A., McCormick, K. L., Miller, M. E., & Sladek, C. D. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80682-1 · Cited by 139
de Kleijn, E. D., de Groot, R., Labadie, J., et al. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00423-5 · Cited by 139
Sáez-Nieto, J. A., Lujan, R., Berrón, S., Campos, J., Viñas, M., Fusté, C., Vázquez, J. A., Zhang, Q. Y., Bowler, L. D., Martı́nez-Suárez, J. V., et al. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.2.394 · Cited by 139
Brandtzaeg, P., Bryn, K., Kierulf, P., Øvstebø, R., Namork, E., Aase, B., & Jantzen, E. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115660 · Cited by 138
Self-citationStephens, D. S., & Farley, M. M. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/13.1.22 · Cited by 138
Dillon, J. R., Yei, K.-H., Pauzé, M., et al. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91846-9 · Cited by 136
High Levels Of Interleukin-10 During The Initial Phase Of Fulminant Meningococcal Septic Shock
Derkx, B., Marchant, A., Goldman, M., Bijlmer, R. P. G. M., & van Deventer, S. J. H. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.1.229 · Cited by 136
EFFECT OF SMOKING ON MENINGOCOCCAL CARRIAGE
Stuart, J. M., Robinson, P., Cartwright, K. V., & Noah, N. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90781-2 · Cited by 135
High levels of interleukin 10 in serum are associated with fatality in meningococcal disease
Lehmann, A. K., Halstensen, A. I., Sørnes, S., Røkke, O., & Waage, A. (1995) · Infection and Immunity · doi:10.1128/iai.63.6.2109-2112.1995 · Cited by 135
Rudel, T., Schmid, A., Benz, R., Kolb, H., Lang, F. J. W., & Meyer, T. F. (1996) · Cell · doi:10.1016/s0092-8674(00)81117-4 · Cited by 134
Haneberg, B., Dalseg, R., Wedege, E., Høiby, E. A., Haugen, I. L., Oftung, F., Andersen, S. R., Næss, L. M., Aase, A., Michaelsen, T. E., et al. (1998) · Infection and Immunity · doi:10.1128/iai.66.4.1334-1341.1998 · Cited by 134
Gerson, W. T., Dickerman, J. D., Bovill, E. G., & Golden, E. A. (1993) · PEDIATRICS · doi:10.1542/peds.91.2.418 · Cited by 132
Kornelisse, R. F., Hazelzet, J. A., Savelkoul, H. F. J., Hop, W. C. J., Suur, M. H., Borsboom, A. N. J., Risseeuw-Appel, I. M., van der Voort, E., & de Groot, R. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.5.1148 · Cited by 132
Meningococcal infections in children: a review of 100 cases.
Wong, V. K., Hitchcock, W. P., & Mason, W. H. (1989) · PubMed · Cited by 129
Borrow, R., Claus, H., Guiver, M., Smart, L. E., JONES, D. M., Kaczmarski, E. B., Frosch, M., & FOX, A. J. (1997) · Epidemiology and Infection · doi:10.1017/s0950268896007261 · Cited by 129
Virji, M., Alexandrescu, C., Ferguson, D. J. P., Saunders, J. R., & Moxon, E. R. (1992) · Molecular Microbiology · doi:10.1111/j.1365-2958.1992.tb00848.x · Cited by 127
Vries, F. P. D., ENDE, A. V. D., van Putten, J. P. M., & Dankert, J. (1996) · Infection and Immunity · doi:10.1128/iai.64.8.2998-3006.1996 · Cited by 126
Schwartz, B., Al-Ruwais, A., A'Ashi, J., Broome, C., Al-Tobaiqi, A., Fontaine, R., Hightower, A., & Music, S. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92069-7 · Cited by 126
Neisseria meningitidis producing the Opc adhesin binds epithelial cell proteoglycan receptors
Vries, F. P. D., Cole, R. L., Dankert, J., Frosch, M., & van Putten, J. P. M. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00763.x · Cited by 124
Prognostic factors in meningococcal disease
Radetsky, M. (1997) · JAMA · doi:10.1001/jama.278.20.1658 · Cited by 124
ASHTON, F. E., Ryan, J. A., Borczyk, A. A., Caugant, D. A., Mancino, L. J. C., & Huang, D. (1991) · Journal of Clinical Microbiology · doi:10.1128/jcm.29.11.2489-2493.1991 · Cited by 121
Removal of pro-inflammatory cytokines with renal replacement therapy: Sense or nonsense?
Schetz, M., Ferdinande, P., den Berghe, G. V., Verwaest, C., & Lauwers, P. (1995) · Intensive Care Medicine · doi:10.1007/bf01726541 · Cited by 121
Adjunctive Therapy for Septic Shock: A Review of Experimental Approaches
Lynn, W. A., & Cohen, J. B. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.1.143 · Cited by 121
Sporadic Meningococcal Disease in Adults: Results of a 5-Year Population-Based Study
Stephens, D. S., Hajjeh, R. A., Baughman, W. S., Harvey, R. C., Wenger, J. D., & Farley, M. M. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-12-199512150-00007 · Cited by 120
Epidemiology and prevention of meningococcal disease
Riedo, F. X., Plikaytis, B. D., & Broome, C. V. (1995) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199508000-00001 · Cited by 119
Extracorporeal support for intractable cardiorespiratory failure due to meningococcal disease
Goldman, A. P., Kerr, S. J., Butt, W. W., Marsh, M. J., Murdoch, I. A., Paul, T., Furnin, R. K., Tasker, R. C., & Macrae, D. J. (1997) · The Lancet · doi:10.1016/s0140-6736(96)12106-1 · Cited by 118
Interleukin-8 in Serum and Cerebrospinal Fluid from Patients with Meningococcal Disease
Halstensen, A. I., Ceska, M., Brandtzaeg, P., et al. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.2.471 · Cited by 115
Self-citationEfficacy of Meningococcal Vaccine and Barriers to Vaccination
Rosenstein, N. E. (1998) · JAMA · doi:10.1001/jama.279.6.435 · Cited by 113
Klein, N. J., ISON, C. A., Peakman, M., Levin, M., Hammerschmidt, S., Frosch, M., & Heyderman, R. S. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.1.172 · Cited by 111
Arditi, M., Ables, L. R., & Yogev, R. (1989) · The Journal of Infectious Diseases · doi:10.1093/infdis/160.6.1005 · Cited by 111
Edwards, E. A., Devine, L. F., Sengbusch, C. H., & Ward, H. (1977) · Scandinavian Journal of Infectious Diseases · doi:10.3109/inf.1977.9.issue-2.09 · Cited by 110
Plasma and Whole Blood Exchange in Meningococcal Sepsis
van Deuren, M., Santman, F. W., van Dalen, R., Sauerwein, R. W., Span, L. F. R., & van der Meer, J. W. M. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.3.424 · Cited by 106
Zwahlen, A., Nydegger, U. E., Vaudaux, P. E., et al. (1982) · The Journal of Infectious Diseases · doi:10.1093/infdis/145.2.635 · Cited by 106
Hack, C. E., Ogilvie, A. C., Eisele, B., Eerenberg, A. J. M., Wagstaff, J., & THIJS, L. G. (1993) · Intensive Care Medicine · doi:10.1007/bf01738946 · Cited by 105
van der Ley, P., & POOLMAN, J. T. (1992) · Infection and Immunity · doi:10.1128/iai.60.8.3156-3161.1992 · Cited by 105
Estabrook, M., Griffiss, J. M., & Jarvis, G. A. (1997) · Infection and Immunity · doi:10.1128/iai.65.11.4436-4444.1997 · Cited by 104
Rapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions.
van Deuren, M., van Dijke, B. J., Koopman, R. J. J., Horrevorts, A. M., Meis, J. F. G. M., Santman, F. W., & van der Meer, J. W. (1993) · BMJ · doi:10.1136/bmj.306.6887.1229 · Cited by 103
Gronp, J. S. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/165.4.695 · Cited by 103
Fluid restriction does not improve the outcome of acute meningitis
Singhi, S. C., SINGH, P. D., Srinivas, B., NARAKESRI, H. P., GANGULI, N. K., Sialy, R., & Walia, B. N. S. (1995) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199506000-00006 · Cited by 102
Ms, S., Nh, M., & Rahal, J. J. (1980) · PubMed · Cited by 101
PLASMA AND WHOLE BLOOD EXCHANGE IN MENINGOCOCCAL SEPSIS
Duren, M. V. (1993) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199305000-00023 · Cited by 100
Cerebral blood flow and carbon dioxide reactivity in children with bacterial meningitis
Ashwal, S., Stringer, W. A., Tomasi, L. G., Schnelder, S., Thompson, J. R., & Perkin, R. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80683-3 · Cited by 100
Prognostic Factors in Meningococcal Disease
Niklasson, P.-M., Lundbergh, P., & STRANDELL, T. (1971) · Scandinavian Journal of Infectious Diseases · doi:10.3109/inf.1971.3.issue-1.03 · Cited by 99
SHIFT IN THE AGE-DISTRIBUTION OF MENINGOCOCCAL DISEASE AS PREDICTOR OF AN EPIDEMIC?
Peltola, H., Kataja, J. M., & Mäkelä, P. H. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90669-9 · Cited by 98
Brandtzaeg, P., Øvstebø, R., & Kierulf, P. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/166.3.650 · Cited by 97
Self-citationde Boer, J. P., Creasey, A. A., Chang, A. C. K., Abbink, J. J., Roem, D., Eerenberg, A. J. M., Hack, C. E., & Taylor, F. B. (1993) · Infection and Immunity · doi:10.1128/iai.61.12.5035-5043.1993 · Cited by 97
Talan, D. A., Hoffman, J. R., Yoshikawa, T. T., & Overturf, G. D. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.2.365 · Cited by 96
van Deuren, M., van der Ven‐Jongekrijg, J., Vannier, E. G., van Dalen, R., Pesman, G. J., Bartelink, A. K. M., Dinarello, C. A., & van der Meer, J. W. M. (1997) · Blood · doi:10.1182/blood.v90.3.1101 · Cited by 95
Epidemic Meningococcal Disease: Synthesis of a Hypothetical Immunoepidemiologic Model
Griffiss, J. M. (1982) · Clinical Infectious Diseases · doi:10.1093/clinids/4.1.159 · Cited by 94
Receptors for transferrin in pathogenic bacteria are specific for the host's protein
Schryvers, A. B., & Gonzalez, G. C. (1990) · Canadian Journal of Microbiology · doi:10.1139/m90-026 · Cited by 92 · cited 1×
“Members of the Neisseriaceae have developed a mechanism for acquiring iron from human transferrin by using transferrin binding proteins (353, 417).”
BackgroundSkin Manifestations of Meningococcal Infection
Toews, W. H. (1974) · American journal of diseases of children · doi:10.1001/archpedi.1974.02110210023003 · Cited by 92
Pili and Outer Membrane Appendages on Neisseria meningitidis in the Cerebrospinal Fluid of an Infant
Stephens, D. S., Edwards, K. M., Morris, F., & McGee, Z. A. (1982) · The Journal of Infectious Diseases · doi:10.1093/infdis/146.4.568 · Cited by 92
Interaction of pathogenic neisseriae with nonphagocytic cells
Nassif, X., & So, M. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.3.376 · Cited by 90
Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome.
Carvalho, A. C. A., DeMarinis, S. M., Scott, C. F., Silver, L. D., Schmaier, A. H., & Colman, R. W. (1988) · PubMed · Cited by 90
Severity of childhood bacterial meningitis and duration of illness before diagnosis
Kilpi, T. M., Anttila, M., Kallio, M., & Peltola, H. (1991) · The Lancet · doi:10.1016/0140-6736(91)91032-p · Cited by 88
Complement Activation in Relation to Capillary Leakage in Children with Septic Shock and Purpura
Hazelzet, J. A., de Groot, R., van Mierlo, G. J., Joosten, K., van der Voort, E., Eerenberg, A. J. M., Suur, M. H., Hop, W. C. J., & Hack, C. E. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5350-5356.1998 · Cited by 87
The Role of Nitric Oxide in Bacterial Meningitis in Children
Kornelisse, R. F., Hoekman, K., Visser, J. J., Hop, W. C. J., Huijmans, J. G. M., van der Straaten, P. J. C., van der Heijden, A. J., Sukhai, R. N., Neijens, H. J., & de Groot, R. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.1.120 · Cited by 87
Prevalence of Neisseria meningitidis Relatively Resistant to Penicillin in the United States, 1991
Jackson, L. A., Tenover, F. C., Baker, C. N., Plikaytis, B. D., Reeves, M. W., Stocker, S., Weaver, R. E., Wenger, J. D., & Study, M. D. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.2.438 · Cited by 84
Activation of the contact system in lethal hypotensive bacteremia in a baboon model.
Pixley, R. A., Cadena, R. A. D., Page, J. D., et al. (1992) · PubMed · Cited by 82
Mustafa, M. M., Mertsola, J., Ramilo, O., Sáez‐Llorens, X., Risser, R. C., & McCracken, G. H. (1989) · The Journal of Infectious Diseases · doi:10.1093/infdis/160.5.891 · Cited by 82
THE CUTANEOUS LESIONS IN ACUTE MENINGOCOCCEMIA
Hill, W. R. (1947) · JAMA · doi:10.1001/jama.1947.02880230023006 · Cited by 82
Intensive blood and plasma exchange for treatment of coagulopathy in meningococcemia
Churchwell, K. B., McManus, M. L., KENT, P. G., Gorlin, J. B., Galacki, D. M., Humphreys, D., & Kevy, S. V. (1995) · Journal of Clinical Apheresis · doi:10.1002/jca.2920100403 · Cited by 80
Age-related Differences in Outcome and Severity of DIC in Children with Septic Shock and Purpura
Hazelzet, J. A., Risseeuw-Appel, I. M., Kornelisse, R. F., Hop, W. C. J., Dekker, I., Joosten, K., de Groot, R., & Hack, C. E. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650688 · Cited by 80
Girardin, E. P., Baumgartner, J. D., Beaufils, F., et al. (1992) · IRIS · Cited by 80
Wylie, P., Stevens, D., Drake, W., Stuart, J., & Cartwright, K. A. V. (1997) · BMJ · doi:10.1136/bmj.315.7111.774 · Cited by 79
Features and outcome in meningococcal disease presenting with maculopapular rash.
Marzouk, O., Thomson, A. P. J., Sills, J. A., Hart, C. A., & Harris, F. (1991) · Archives of Disease in Childhood · doi:10.1136/adc.66.4.485 · Cited by 79
Analysis of emergency department management of suspected bacterial meningitis
Talan, D. A., Guterman, J. J., Overturf, G. D., Singer, C., Hoffman, J. R., & Lambert, B. (1989) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(89)80213-6 · Cited by 77
The outcome of children admitted to intensive care with meningococcal septicaemia
Mok, Q., & Butt, W. W. (1996) · Intensive Care Medicine · doi:10.1007/bf01712247 · Cited by 77
Fijen, C. A. P., Kuijper, E. J., Tjia, H. G., et al. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.5.780 · Cited by 76
Dysfunctional Properdin in a Dutch Family with Meningococcal Disease
Sjöholm, A. G., Kuijper, E. J., Tijssen, C. C., Jansz, A., Bol, P., Spanjaard, L., & Zanen, H. C. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807073190106 · Cited by 76
Serogroup Y Meningococcal Disease in Chicago, 1991-1997
Racoosin, J. A. (1998) · JAMA · doi:10.1001/jama.280.24.2094 · Cited by 76
Interaction of complement with Neisseria meningitidis and Neisseria gonorrhoeae
Densen, P. (1989) · Clinical Microbiology Reviews · doi:10.1128/cmr.2.suppl.s11 · Cited by 71
López-Cortés, L. F., Cruz-Ruiz, M., Gómez-Mateos, J. M., Jiménez-Hernández, D., Palomino, J., & Jiménez, E. (1993) · Clinical Infectious Diseases · doi:10.1093/clind/16.4.534 · Cited by 71
Meningococcal Disease in the United States--1986
Pinner, R. W., Gellin, B. G., Bibb, W. F., Baker, C. N., Weaver, R. E., Hunter, S. B., Waterman, S. H., Mocca, L. F., Frasch, C. E., Broome, C. V., et al. (1991) · The Journal of Infectious Diseases · doi:10.1093/infdis/164.2.368 · Cited by 71
Gedde-Dahl, T. W., Bjark, P. H., Heiby, E. A., Hest, J. H., & Bruun, J. N. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.6.973 · Cited by 69
Cited by
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Raetz, C. R. H., & Whitfield, C. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135414 · Cited by 4,404
Epidemic meningitis, meningococcaemia, and Neisseria meningitidis
Stephens, D. S., Greenwood, B., & Brandtzaeg, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61016-2 · Cited by 978
Self-citationIntracellular Targeting Mechanisms by Antimicrobial Peptides
Le, C.-F., Fang, C.-M., & Sekaran, S. D. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02340-16 · Cited by 603
Clinical recognition of meningococcal disease in children and adolescents
Thompson, M. J., Ninis, N., Perera, R., Mayon-White, R., Phillips, C., Bailey, L., Harnden, A., Mant, D., & Levin, M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)67932-4 · Cited by 565
Metadata
- Authors
- van Deuren, M., Brandtzaeg, P., & van der Meer, J. W. M.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2000-01
- Volume
- 13
- Issue
- 1
- Pages
- 144-166
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2096532993
- Cited by
- 588
- References
- 287
- FWCI
- 25.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.